EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $2,401,000 | +24.4% | 140,000 | -12.2% | 0.35% | +34.2% |
| Q4 2016 | $1,930,000 | +22.9% | 159,513 | 0.0% | 0.26% | +50.3% |
| Q3 2016 | $1,570,000 | -3.9% | 159,513 | 0.0% | 0.17% | -25.4% |
| Q2 2016 | $1,633,000 | -49.4% | 159,513 | -40.1% | 0.23% | -52.3% |
| Q1 2016 | $3,227,000 | -24.3% | 266,250 | 0.0% | 0.49% | -4.7% |
| Q4 2015 | $4,265,000 | +24.6% | 266,250 | 0.0% | 0.51% | -6.8% |
| Q3 2015 | $3,424,000 | -46.4% | 266,250 | 0.0% | 0.55% | -35.6% |
| Q2 2015 | $6,390,000 | +27.8% | 266,250 | 0.0% | 0.85% | +10.0% |
| Q1 2015 | $5,000,000 | – | 266,250 | – | 0.77% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 9,166,667 | $109,358,000 | 16.39% |
| Burrage Capital Management LLC | 1,002,528 | $11,960,000 | 9.44% |
| Foresite Capital Management III, LLC | 998,278 | $11,909,000 | 8.87% |
| MPM BioImpact LLC | 2,854,737 | $34,057,000 | 8.20% |
| Palo Alto Investors LP | 6,403,600 | $76,395,000 | 4.19% |
| Foresite Capital Management II, LLC | 862,402 | $10,288,000 | 2.24% |
| Redmile Group, LLC | 8,311,633 | $99,158,000 | 1.82% |
| Pier Capital, LLC | 574,299 | $6,851,000 | 1.00% |
| Foresite Capital Management I, LLC | 243,759 | $2,908,000 | 0.82% |
| Rock Springs Capital Management LP | 2,551,659 | $30,441,000 | 0.77% |